Inizio Group Limited
Inizio Group Limited, headquartered in Great Britain, is a leading player in the healthcare and life sciences industry. Founded in 2021, the company has rapidly established itself as a trusted partner for organisations seeking innovative solutions in clinical development, commercialisation, and market access. With a strong presence across Europe and North America, Inizio Group offers a diverse range of services, including strategic consulting, data analytics, and patient engagement. What sets Inizio Group apart is its commitment to delivering tailored solutions that enhance patient outcomes and drive business success. The company has achieved significant milestones, positioning itself as a go-to resource for pharmaceutical and biotechnology firms. With a focus on collaboration and excellence, Inizio Group Limited continues to shape the future of healthcare, making a meaningful impact in the industry.
DitchCarbon Score
How does Inizio Group Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Inizio Group Limited's score of 66 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Inizio Group Limited's reported carbon emissions
Inizio Group Limited, headquartered in Great Britain, reported a total of approximately 11,380,000 kg CO2e in carbon emissions for the year 2023. This figure includes about 5,919,000 kg CO2e from Scope 1 emissions, primarily from mobile and stationary combustion, and approximately 3,746,000 kg CO2e from Scope 2 emissions. The company also recorded about 30,210,000 kg CO2e in Scope 3 emissions, which encompass business travel, employee commuting, and purchased goods and services. Inizio Group has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 46.2% by 2031, using 2021 as the baseline year. Additionally, the company targets a 27.5% reduction in absolute Scope 3 emissions from purchased goods and services, fuel- and energy-related activities, and business travel within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are consistent with the reductions necessary to limit global warming to 1.5°C. Overall, Inizio Group Limited is actively working towards significant emissions reductions, demonstrating a commitment to sustainability and climate responsibility in the pharmaceuticals, biotechnology, and life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 8,008,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 2,846,000 | 000,000 | 000,000 | 000,000 |
| Scope 3 | 18,679,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Inizio Group Limited is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
